(Medical Xpress)—People given a choice between generic or branded drugs should look closely at the ingredients in the drug they are buying, argue economists from Deakin University's Graduate School of Business.
Sep 16, 2013
0
0
(AP) -- The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition.
Feb 9, 2012
1
0
Women are still disadvantaged in society, particularly professionally. They are frequently paid less than men and find it more difficult to have a successful career. One reason for this may be the fact that women are observed ...
Oct 23, 2018
0
30
Exercise has been found to reduce stress, increase positive mood, decrease anxiety and alleviate depression. But you may not know that the emotional well-being associated with exercise is also linked to key attributes that ...
Jan 18, 2019
0
6
Greater brand-brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's ...
Jul 30, 2019
0
4
Cells carrying mutations can out compete early tumors in the mouse esophagus, so they never make it into cancers, new research has shown.
Oct 13, 2021
0
23
A normal process called cell competition, in which healthy tissues eliminate unhealthy cells, could be responsible for cancer relapses in patients months or years after they were declared cancer-free, a new study by UT Southwestern ...
Nov 8, 2022
0
54
The European Commission on Wednesday authorised a merger of US drug giant Pfizer's off-patent business unit with the pharmaceutical company Mylan to create a global powerhouse for lower-cost medicines.
Apr 22, 2020
0
4
(Medical Xpress)—Certificate of Need, a form of state government regulation designed to keep mortality rates and health care costs down, appears to do neither for heart bypass surgery, according to a health economics researcher ...
Oct 3, 2012
0
0
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Apr 16, 2013
1
0
